CymitQuimica logo
Chk

Chk

Gli inibitori delle chinasi di checkpoint (Chk) prendono di mira le chinasi Chk1 e Chk2, che sono regolatori chiave della risposta ai danni del DNA e dei punti di controllo del ciclo cellulare. Queste chinasi bloccano la progressione del ciclo cellulare in risposta ai danni al DNA, consentendo il tempo necessario per la riparazione. L'inibizione delle chinasi Chk può impedire l'arresto del ciclo cellulare, costringendo le cellule danneggiate a proseguire nel ciclo e a subire l'apoptosi. Gli inibitori di Chk sono particolarmente preziosi nella ricerca sul cancro, dove possono sensibilizzare le cellule tumorali agli agenti che danneggiano il DNA. Presso CymitQuimica, offriamo una varietà di inibitori di Chk di alta qualità per supportare la tua ricerca sulla risposta ai danni del DNA, la regolazione del ciclo cellulare e l'oncologia.

Trovati 46 prodotti di "Chk"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • Monalizumab

    CAS:
    Monalizumab, a humanized antibody, enhances NK cell function by inhibiting NKG2A; used in HNSCC studies.
    Purezza:95% - >95.0% (SDS-PAGE); 100% (SEC-HPLC)
    Colore e forma:Liquid
    Peso molecolare:147 kDa (average)
  • CHK1-IN-4 hydrochloride


    CHK1-IN-4 hydrochloride is a potent inhibitor of checkpoint kinase 1 (chk1).
    Formula:C18H19BrClN7O2
    Purezza:99.29%
    Colore e forma:Soild
    Peso molecolare:480.75
  • CHK1-IN-12


    CHK1-IN-12 (Compound example 1-5) is a highly selective and orally active checkpoint kinase 1 (CHK1) inhibitor, demonstrating an in vitro enzyme IC50 of ≤10 nM and a cellular IC50 of ≤50 nM. This compound suppresses the phosphorylation activity of CHK1 kinase, disrupts DNA damage response pathways, and induces tumor cell cycle arrest and apoptosis. CHK1-IN-12 shows promise for cancer research applications.
    Formula:C19H19N7O2
    Colore e forma:Solid
    Peso molecolare:377.16002
  • Zimistobart

    CAS:
    Zimistobart (BMS-986315) is a fully human IgG1 antibody that targets and binds to NKG2A. It is applicable in research for non-small cell lung cancer (NSCLC). For an isotype control, refer to HumanIgG1kappa, Isotype Control.
    Colore e forma:Liquid
  • CCT241533 dihydrochloride

    CAS:
    Potent Chk2 inhibitor with 3 nM IC50, 63-fold more selective over Chk1, affects 84 kinases, reduces DNA damage response and apoptosis in cells.
    Formula:C23H29Cl2FN4O4
    Colore e forma:Solid
    Peso molecolare:515.41
  • CBP501 Affinity Peptide

    CAS:
    CBP501 Affinity Peptide, a Chk kinase inhibitor, disrupts G2 arrest triggered by DNA-damaging agents and is utilized in cancer research [1].
    Formula:C68H119N21O25S
    Colore e forma:Solid
    Peso molecolare:1662.86
  • CHK1-IN-9


    CHK1-IN-9 (compound 11) is an orally active CHK1 inhibitor with an IC50 of 0.55 nM. It enhances the effects of DNA-damaging agents on tumor cells and exhibits synergistic anticancer activity with Gemcitabine.
  • WAY-230563

    CAS:
    <p>WAY-230563 is a serine/threonine kinase inhibitor that blocks CHK1/CHK2-mediated cell cycle checkpoints, leading to G2/M phase arrest in tumour cells</p>
    Formula:C17H12N2O2S
    Purezza:98.40%
    Colore e forma:Solid
    Peso molecolare:308.35
  • Chk1-IN-6

    CAS:
    <p>Chk1-IN-6 is a potent, selective, and orally bioavailable CHK1 inhibitor candidate.</p>
    Formula:C16H18F3N7
    Colore e forma:Solid
    Peso molecolare:365.364
  • GDC-0425

    CAS:
    <p>GDC-0425 (RG-7602), an oral selective ChK1 inhibitor, targets multiple cancers.</p>
    Formula:C18H19N5O
    Colore e forma:Solid
    Peso molecolare:321.38
  • PD 407824

    CAS:
    PD 407824 is a chemical BMP sensitiser that promotes increased cellular sensitivity to subthreshold amounts of BMP4.PD 407824 is a potent inhibitor of the checkpoint kinases Chk1 and WEE1 (IC50s: 47 and 97 nM, respectively).
    Formula:C20H12N2O3
    Purezza:98.02%
    Colore e forma:Solid
    Peso molecolare:328.32
  • GDC-0575 dihydrochloride

    CAS:
    GDC-0575 dihydrochloride (ARRY-575 dihydrochloride) is a selective, orally active CHK1 inhibitor (IC50: 1.2 nM) that exhibits antitumour effects.
    Formula:C16H22BrCl2N5O
    Colore e forma:Solid
    Peso molecolare:451.19
  • CCT244747

    CAS:
    CCT244747 is a potent and selective CHK1 inhibitor oral, ATP-competitive, and cytotoxic, abrogating drug-induced S and G2 blockade and inducing apoptosis .
    Formula:C20H24N8O2
    Purezza:99.17%
    Colore e forma:Solid
    Peso molecolare:408.46
  • GDC0575 monohydrochloride

    CAS:
    <p>GDC0575 (ARRY575), a potent Chk1 inhibitor, IC50 1.2nM, disrupts cell cycle arrest, allowing DNA repair before mitosis.</p>
    Formula:C16H21BrClN5O
    Purezza:97.85%
    Colore e forma:Solid
    Peso molecolare:414.73
  • CCT245737

    CAS:
    CCT245737 is an orally active, selective Chk1 inhibitor, and is >1,000-fold selective over CHK2 and CDK1.Cost-effective and quality-assured.
    Formula:C16H16F3N7O
    Purezza:98.28% - 99.93%
    Colore e forma:Solid
    Peso molecolare:379.34
  • AZD-7762

    CAS:
    AZD-7762, an effective and specific inhibitor of Chk1(IC50=5 nM), is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck.
    Formula:C17H19FN4O2S
    Purezza:98.96% - 99.19%
    Colore e forma:Solid
    Peso molecolare:362.42
  • M2I-1

    CAS:
    M2I-1 inhibits Mad2 binding to Cdc20, disrupting SAC-related PPI and Mad2 dynamics, blocks Mad2-F-Mbp1 in FP assays.
    Formula:C19H24N4O4S
    Purezza:99.02% - >99.99%
    Colore e forma:Solid
    Peso molecolare:404.48
  • GDC-0575

    CAS:
    <p>GDC-0575 (ARRY-575) is a highly-selective oral small-molecule Chk1 inhibitor(IC50 of 1.2 nM).</p>
    Formula:C16H20BrN5O
    Purezza:≥95%
    Colore e forma:Solid
    Peso molecolare:378.27
  • Rabusertib

    CAS:
    <p>Rabusertib (IC-83) is a chk1 inhibitor in trials for various cancers, including pancreatic and non-small cell lung cancer.</p>
    Formula:C18H22BrN5O3
    Purezza:98.86% - 99.87%
    Colore e forma:Solid
    Peso molecolare:436.3
  • LY2880070

    CAS:
    LY2880070 is a new checkpoint kinase 1 (CHK1) inhibitor for cancer therapy.
    Formula:C19H23N7O2
    Purezza:99.77%
    Colore e forma:Solid
    Peso molecolare:381.43